Everyone living with and affected by diabetes is excited about artificial pancreas research and the various innovations spawned by this remarkable technology.
In this episode of Diabetes By The Numbers, I'm joined by Molly McElwee Malloy, who has just recently stepped into her latest role as Head of Patient Engagement at Type Zero Technologies. She is an RN and Certified Diabetes Educator who has been living with diabetes since 1998. She knows the relationship of diabetes, analytics, and technology like almost no other person I know.
Type Zero is the continuation of artificial pancreas research started at the University of Virginia at their Center for Diabetes Technology. In our conversation, we talk about the birth of Type Zero, its InControl platfrom including InControl Advice and InControl Cloud, and the timeline for development, testing, and submission for approval to the U.S. Food and Drug Administration.
Type Zero Technologies:typezero.comInterested in participating in a Type Zero clinical trial? Send an e-mail to:firstname.lastname@example.org